COX‐2 and cancer: a new approach to an old problem
- 1 November 2001
- journal article
- review article
- Published by Wiley in British Journal of Pharmacology
- Vol. 134 (6) , 1137-1150
- https://doi.org/10.1038/sj.bjp.0704365
Abstract
No abstract availableKeywords
This publication has 138 references indexed in Scilit:
- Nuclear Factor-κB Regulates Cyclooxygenase-2 Expression and Cell Proliferation in Human Gastric Cancer CellsLaboratory Investigation, 2001
- The Role of Cyclooxygenase and Lipoxygenase in Cancer ChemopreventionDrug Metabolism and Drug Interactions, 2000
- PPAR-γ agonists: therapeutic role in diabetes, inflammation and cancerTrends in Pharmacological Sciences, 2000
- The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous PolyposisNew England Journal of Medicine, 2000
- The effect of non-steroidal anti-inflammatory drugs on human colorectal cancer cellsEuropean Journal Of Cancer, 2000
- Cancer chemoprevention through interruption of multistage carcinogenesisEuropean Journal Of Cancer, 2000
- NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, EICOSANOIDS, AND COLORECTAL CANCER PREVENTIONGastroenterology Clinics of North America, 1996
- Self-Promotion? Intimate Connections Between APC and Prostaglandin H Synthase-2Cell, 1996
- Long-term use of nonsteroidal antiinflammatory drugs and other chemopreventors and risk of subsequent colorectal neoplasiaDigestive Diseases and Sciences, 1996
- NSAID USE AND DECREASED RISK OF GASTROINTESTINAL CANCERSGastroenterology Clinics of North America, 1996